BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24659748)

  • 1. Necrobiotic xanthogranuloma.
    Jaén-Águila F; Vargas-Hitos JA; Jiménez-Alonso J
    QJM; 2014 Oct; 107(10):859. PubMed ID: 24659748
    [No Abstract]   [Full Text] [Related]  

  • 2. Necrobiotic Xanthogranuloma.
    Dellatorre G; Miqueloto JK
    JAMA Dermatol; 2020 Jun; 156(6):696. PubMed ID: 32374351
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of necrobiotic xanthogranuloma with total glucosides of paeony.
    Li S; Chen AJ; Fang S; Li H
    Dermatol Ther; 2014; 27(5):304-6. PubMed ID: 24774012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral necrobiotic xanthogranuloma of the eyelids followed by a diagnosis of multiple myeloma 20 years later.
    Lam K; Brownstein S; Jordan DR; van der Jagt R; Jastrzebski A; Dionne MA
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):e119-20. PubMed ID: 23247037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrobiotic Xanthogranuloma Treated With Topical Nitrogen Mustard (Mechlorethamine).
    Rodriguez O; Meyers C; Weiss BM; Elenitsas R; Rosenbach M
    JAMA Dermatol; 2016 May; 152(5):589-90. PubMed ID: 26762214
    [No Abstract]   [Full Text] [Related]  

  • 7. Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone.
    Dholaria BR; Cappel M; Roy V
    Ann Hematol; 2016 Mar; 95(4):671-2. PubMed ID: 26814914
    [No Abstract]   [Full Text] [Related]  

  • 8. Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.
    Ghani S; Al Ustwani O; Khalid B; Bogner P; Grassi M; Powell J; Bhat SA
    Clin Adv Hematol Oncol; 2013 Oct; 11(10):678-80. PubMed ID: 24518382
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immunoglobulin for treatment of necrobiotic xanthogranuloma.
    Goyal A; O'Leary D; Vercellotti G; Miller D; McGlave P
    Dermatol Ther; 2019 Jan; 32(1):e12744. PubMed ID: 30221815
    [No Abstract]   [Full Text] [Related]  

  • 10. Necrobiotic Xanthogranuloma.
    Portuguese AJ; Long TH; Linenberger M
    Mayo Clin Proc; 2021 Sep; 96(9):2432-2434. PubMed ID: 34481598
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission of multiple myeloma.
    Adam Z; Řehák Z; Adamová Z; Pour L; Dvořáková K; Packová B; Koukalová R; Krejčí M; Krejčí M; Štork M; Sandecká V; Boichuk I; Král Z
    Klin Onkol; 2022; 35(4):315-322. PubMed ID: 35989089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrobiotic xanthogranuloma in IgG-κ multiple myeloma.
    Giacalone S; Genovese G; Benzecry V; Berti E; Cusini M
    Br J Haematol; 2021 Apr; 193(2):211. PubMed ID: 33529369
    [No Abstract]   [Full Text] [Related]  

  • 13. Necrobiotic xanthogranuloma of the extremities.
    Wolz M; Peters MS
    J Drugs Dermatol; 2012 Jan; 11(1):122-3. PubMed ID: 22206088
    [No Abstract]   [Full Text] [Related]  

  • 14. Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.
    Mello RB; Vale ECSD
    An Bras Dermatol; 2019 Jul; 94(3):337-340. PubMed ID: 31365665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for necrobiotic xanthogranuloma.
    Ali FR; Lear JT
    Clin Exp Dermatol; 2022 Apr; 47(4):769-770. PubMed ID: 34856016
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    Nguyen BD
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1667. PubMed ID: 28948701
    [No Abstract]   [Full Text] [Related]  

  • 17. Periorbital necrobiotic xanthogranuloma and stage I multiple myeloma. Ultrastructure and response to pulsed dexamethasone documented by magnetic resonance imaging.
    Plotnick H; Taniguchi Y; Hashimoto K; Negendank W; Tranchida L
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):373-7. PubMed ID: 1894775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.
    Efebera Y; Blanchard E; Allam C; Han A; Lee S; Munshi N
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):298-302. PubMed ID: 21658660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary necrobiotic xanthogranuloma of an upper extremity in association with multiple myeloma.
    Bain EE; Meehan SA; Hale EK
    J Drugs Dermatol; 2014 May; 13(5):598-600. PubMed ID: 24809886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.